Utilization of antiretroviral therapy services and associated factors among adolescents living with HIV in northern Uganda: A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
04
2023
accepted:
26
06
2023
medline:
17
7
2023
pubmed:
13
7
2023
entrez:
13
7
2023
Statut:
epublish
Résumé
Suboptimal utilization of antiretroviral therapy (ART) services remains a problem among adolescents in low- and middle-income countries, which has a negative impact on their response to treatment and increases the risk of developing resistance. Optimal use is essential to enhancing treatment efficacy. We investigated the optimal use of ART service and predictors among adolescents living with HIV (ALHIV) in northern Uganda. We used a cross-sectional study design to collect quantitative data from 293 ALHIV at three health facilities in Lira municipality, northern Uganda. We used an interviewer-administered questionnaire and data abstraction form. Data were analysed using SPSS version 23 software. Descriptive analysis and logistic regressions were performed to determine the relationship between the predictor and outcome variables. Statistical significance was determined at P-value<0.05 and the adjusted odds ratio with a 95% confidence interval was used. The level of utilization of ART services was suboptimal among 27.6% (81/293) of the participants, and only 63.1% (185/293) were virally suppressed. Of the participants who were optimally utilizing ART services, the majority 86.8% (184/212) were virally suppressed. Age 10-14 years (aOR = 3.34), the presence of both parents (aOR = 1.85), parental and peer reminders (aOR = 2.91) and (aOR = 0.49) respectively, and being on ART for five years or less were the characteristics related with optimal utilization of ART services. Not all ALHIV used ART services to their full potential. However, factors such as participants' age, the presence of both parents, reminders from parents and peers, and being on ART for some time were all related to the optimal use of ART services. There is a need for developing strategies to increase family and peer support with a focus on older adolescents if the 95-95-95 goal is to be achieved in this age group.
Sections du résumé
BACKGROUND
BACKGROUND
Suboptimal utilization of antiretroviral therapy (ART) services remains a problem among adolescents in low- and middle-income countries, which has a negative impact on their response to treatment and increases the risk of developing resistance. Optimal use is essential to enhancing treatment efficacy. We investigated the optimal use of ART service and predictors among adolescents living with HIV (ALHIV) in northern Uganda.
METHODS
METHODS
We used a cross-sectional study design to collect quantitative data from 293 ALHIV at three health facilities in Lira municipality, northern Uganda. We used an interviewer-administered questionnaire and data abstraction form. Data were analysed using SPSS version 23 software. Descriptive analysis and logistic regressions were performed to determine the relationship between the predictor and outcome variables. Statistical significance was determined at P-value<0.05 and the adjusted odds ratio with a 95% confidence interval was used.
RESULTS
RESULTS
The level of utilization of ART services was suboptimal among 27.6% (81/293) of the participants, and only 63.1% (185/293) were virally suppressed. Of the participants who were optimally utilizing ART services, the majority 86.8% (184/212) were virally suppressed. Age 10-14 years (aOR = 3.34), the presence of both parents (aOR = 1.85), parental and peer reminders (aOR = 2.91) and (aOR = 0.49) respectively, and being on ART for five years or less were the characteristics related with optimal utilization of ART services.
CONCLUSIONS AND RECOMMENDATIONS
CONCLUSIONS
Not all ALHIV used ART services to their full potential. However, factors such as participants' age, the presence of both parents, reminders from parents and peers, and being on ART for some time were all related to the optimal use of ART services. There is a need for developing strategies to increase family and peer support with a focus on older adolescents if the 95-95-95 goal is to be achieved in this age group.
Identifiants
pubmed: 37440577
doi: 10.1371/journal.pone.0288410
pii: PONE-D-23-11706
pmc: PMC10343037
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0288410Informations de copyright
Copyright: © 2023 Odongo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Infect Dis. 2014 May;58(9):1297-307
pubmed: 24457345
AIDS Patient Care STDS. 2006 Jun;20(6):418-28
pubmed: 16789855
Afr Health Sci. 2022 Jun;22(2):54-62
pubmed: 36407355
Syst Rev. 2020 Jul 14;9(1):160
pubmed: 32665026
J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71
pubmed: 19282780
BMC Public Health. 2019 Oct 28;19(1):1382
pubmed: 31660947
AIDS. 2012 May 15;26(8):929-38
pubmed: 22313953
PLOS Glob Public Health. 2022 Jun 2;2(6):e0000418
pubmed: 36962329
BMC Infect Dis. 2018 Nov 14;18(1):566
pubmed: 30428835
BMC Infect Dis. 2020 Jun 22;20(1):439
pubmed: 32571232
AIDS Care. 2008 Aug;20(7):842-52
pubmed: 18608054
AIDS. 2005 Sep 23;19(14):1501-8
pubmed: 16135904
PLoS One. 2021 Apr 29;16(4):e0249971
pubmed: 33914770
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e15-e18
pubmed: 28394821
AIDS. 2014 Feb 20;28(4):559-68
pubmed: 24076661
Biomed Res Int. 2018 May 06;2018:1524016
pubmed: 29854727
Trop Med Int Health. 2012 Jan;17(1):71-81
pubmed: 21967241
AIDS Res Ther. 2017 Mar 21;14:16
pubmed: 28331527
PLoS One. 2017 Feb 16;12(2):e0172392
pubmed: 28207891
Vulnerable Child Youth Stud. 2019;14(2):181-190
pubmed: 31149021
J Int AIDS Soc. 2015 Sep 16;18:20049
pubmed: 26385853
Curr HIV/AIDS Rep. 2019 Dec;16(6):467-474
pubmed: 31776974
AIDS. 2001 Jun 15;15(9):1181-3
pubmed: 11416722
Clin Infect Dis. 2003 May 1;36(9):1177-85
pubmed: 12715314
HIV AIDS (Auckl). 2013;5:1-17
pubmed: 23326204
Reprod Health. 2018 Oct 24;15(1):180
pubmed: 30355344
BMC Infect Dis. 2015 Jan 31;15:28
pubmed: 25637106
BMC Infect Dis. 2018 Feb 20;18(1):83
pubmed: 29458343
Ann Behav Med. 2011 Aug;42(1):111-9
pubmed: 21494925